Hills Bank & Trust’s AstraZeneca AZN Stock Holding History

Hills Bank & Trust’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$114K	Buy	+602	New	+$113K	﹤0.01%	364
2026 Q1	–	Sell	-725	Closed	-$133K	–	356
2025 Q4	$133K	Hold	725	–	–	0.01%	304
2025 Q3	$111K	Sell	725 -5	-0.7%	-$757	0.01%	311
2025 Q2	$102K	Sell	730 -58	-7%	-$8.13K	0.01%	308
2025 Q1	$116K	Hold	788	–	–	0.01%	291
2024 Q4	$103K	Buy	788 +18	+2%	+$2.52K	0.01%	299
2024 Q3	$120K	Hold	770	–	–	0.01%	286
2024 Q2	$120K	Sell	770 -80	-9%	-$12K	0.01%	275
2024 Q1	$115K	Hold	850	–	–	0.01%	273
2023 Q4	$114K	Sell	850 -26	-3%	-$3.38K	0.01%	265
2023 Q3	$119K	Sell	876 -13	-1%	-$1.78K	0.01%	248
2023 Q2	$127K	Sell	889 -222	-20%	-$32.7K	0.02%	235
2023 Q1	$154K	Sell	1,111 -369	-25%	-$49.6K	0.02%	224
2022 Q4	$201K	Sell	1,480 -359	-20%	-$45K	0.03%	202
2022 Q3	$202K	Sell	1,839 -450	-20%	-$57.1K	0.03%	191
2022 Q2	$303K	Sell	2,289 -775	-25%	-$102K	0.05%	169
2022 Q1	$407K	Sell	3,064 -1,420	-32%	-$170K	0.06%	151
2021 Q4	$522K	Sell	4,484 -31	-0.7%	-$3.65K	0.07%	141
2021 Q3	$542K	Buy	+4,515	New	+$526K	0.08%	134

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Hills Bank & Trust's AZN Position: Q2 2026 in Review

Hills Bank & Trust opened a new position in AstraZeneca (AZN) in Q2 2026: 602 shares worth $114K. The stake represents ﹤0.01% of the portfolio and ranks #364 among its holdings. This is a return to the name: Hills Bank & Trust previously reported a position in AZN as recently as Q4 2025.

Hills Bank & Trust first reported a position in AZN in Q3 2021 and has held it in 19 quarters since. The position peaked at $542K in Q3 2021. 1,504 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Hills Bank & Trust held 602 shares of AstraZeneca worth $114K as of Q2 2026.
AstraZeneca was a new Hills Bank & Trust position in Q2 2026.
AstraZeneca made up ﹤0.01% of Hills Bank & Trust's portfolio in Q2 2026, its #364 holding.
Hills Bank & Trust first reported a position in AstraZeneca in Q3 2021 and has held it in 19 quarters since.
Hills Bank & Trust's AstraZeneca position peaked at $542K in Q3 2021.
1,504 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Hills Bank & Trust's 13F filing for Q2 2026, filed 10 Aug 2026.